Camber
Valganciclovir Tablet, Film Coated
Product Images NDC 31722-832
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 31722-832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Formula
Formula2
This text appears to be describing a chart or table that provides information on serum creatinine levels and their relationship to the Schwartz Creatinine Clearance rate, measured in mL/min/1.73m². The chart likely includes values for different heights in em (unknown unit of measurement given in the text).*
Label
Valganciclovir is a prescription medication in tablet form, with each film-coated tablet containing 496.3 mg of Valganciclovir Hydrochloride LISP, equivalent to 450 mg of valganciclovir. It is manufactured by Camber Pharmaceuticals and is used to treat infections caused by certain viruses. The dosage instructions are available in the package insert, and it is essential to follow the recommended dosage to avoid overdose. The medication should be stored between 15° and 30°C (5 and 86°F) in controlled room temperature conditions. Breaking or crushing the tablets is not recommended. For more information, visit the Camber Pharmaceuticals website.*
Valganstructure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
